Accelerating discoveries for better health
CCI FY21 prices have been established and will be effective starting October 1, 2020. All prices for FY21 will remain the same as FY20 with the exception of telemetry and the industry rate for Phlebotomy/EKG/Vitals training. Please don’t hesitate to contact us at CCI@bwh.harvard.edu with any questions or concerns.
The Center for Clinical Investigation will have reduced hours over the holidays in Dec and Jan. If you need visit support during reduced hours, please email CCI@bwh.harvard.edu. Our team will work with you to schedule visits and clinical support staff during this time. Outpatient Centers: Close end of business (ACC, CTH 4:00pm; CTC 6:00pm; ROC-B
CCI’s 2020 Holiday Operational Hours Read More »
June 11, 2020 Dear Investigators, We are pleased to announce the CCI is re-opening our outpatient clinics and inpatient pods in support of clinical research visits. We will be following current BWH research guidance, which states that all visits and visit procedures that can reasonably continue to be conducted remotely should not be scheduled as onsite
CCI Outpatient & Inpatient Re-Opening Communication Read More »
Harvard Catalyst Biostatistical Consulting Program and the Center for Clinical Investigation at BWH offer weekly consultations virtually during COVID 19 pandemic. No reservation is required, and it is free. Biostatisticians will answer your statistical questions, guide you to more in-depth support, and will be available for both short- and long-term collaborations. Office Hours: Tuesdays, 1:00pm-2:00pmPlease
Biostats Virtual Office Hours Read More »
We would first like to thank you for your flexibility with the CCI and research community as we navigate these unprecedented times. As we all know this situation is rapidly evolving and changing, on a daily basis. Our email on 3/16/20 notified you that we have closed down all CCI ambulatory/inpatient locations except for the
CCI COVID-19 Resources for Virtual Visits, IRB amendments, IDS Changes Read More »
In response to the rapid spread of COVID-19, we have been directed in guidance with CDC recommendations and Partners Policy to minimize to the number of personnel working in our CCI Spaces and laboratories. We realize that our investigators are working hard to improve our understanding of disease and develop new treatments for our patients,
CCI Research Spaces Closing for Non-Therapeutic Trials Immediately Read More »
As many of you are aware, Partners has initiated many emergency response efforts for the COVID-19 outbreak to implement strategies that support our abilities to fulfill our core mission. The CCI is dedicated to protecting our patients, frontline health care workers, and doing everything possible to provide an adequate workforce for the caring of our
COVID-19 CCI Updates 3-13-20 Read More »